DreaMed Diabetes is a pioneering digital health company specializing in artificial intelligence (AI) and machine learning solutions for people with diabetes. Based in Israel, the company's flagship product, DreaMed Advisor, is an advanced diabetes management system that integrates with continuous glucose monitors and insulin pumps to provide personalized insulin dosing recommendations. DreaMed Advisor uses AI algorithms to analyze real-time glucose data and insulin delivery history, offering personalized insulin dosing suggestions to improve glucose control and reduce the risk of hypoglycemia and hyperglycemia. The system also offers predictive alerts for upcoming highs and lows, enabling users to take proactive steps to maintain optimal glucose levels. DreaMed Diabetes' mission is to revolutionize diabetes care by providing innovative, data-driven solutions that empower people with diabetes to live healthier, more balanced lives.'
1. DreaMed Diabetes offers personalized insulin dosing recommendations for people with diabetes using artificial intelligence and machine learning algorithms, integrating real-time data from continuous glucose monitors and insulin pumps.
2. The company's solution, called "DreaMed Advisor," provides real-time insulin dosing suggestions, taking into account individual patient data, food intake, and activity levels to optimize glucose management.
3. DreaMed Diabetes differentiates itself from competitors by focusing on insulin dosing recommendations, while others may offer only glucose forecasting or general diabetes management tools.
4. The company has partnerships with major diabetes device manufacturers, such as Medtronic and Dexcom, to seamlessly integrate their technology into existing diabetes management systems.
5. DreaMed Diabetes has received FDA clearance for its solution and is available in the United States, Europe, and other markets, positioning it as a global player in the digital diabetes management space.
1. DreaMed Diabetes provides advanced diabetes analytics and personalized insulin dosing recommendations through its AI-powered digital platform.
2. The company's Business Intelligence solution leverages real-time data from continuous glucose monitors, insulin pumps, and other health data sources to optimize insulin dosing and improve diabetes management.
3. DreaMed's AI algorithms analyze complex data patterns to provide personalized insulin dosing suggestions, taking into account factors such as meal intake, physical activity, and glucose trends.
4. The platform integrates with multiple diabetes devices and health systems, allowing healthcare providers to remotely monitor and adjust insulin dosing for their patients in real-time.
5. DreaMed's Business Intelligence solution has been shown to improve glycemic control, reduce hypoglycemia, and increase patient satisfaction in clinical studies.
Browse Our Research Portfolio In DreaMed Diabetes Markets
Health Care
Health Care Technology
Health Care Technology
About Technavio
With unparalleled market insights, our research is designed to elevate your business to new heights. Technavio stands at the forefront of market research with a global perspective. Our approach is grounded in four key principles: accessible reports, comprehensive industry analysis, a focus on innovative and emerging technologies, and competitive pricing. We are dedicated to empowering companies and executives to make informed, timely, and strategic decisions.